Entity Details

Primary name CFB
Entity type gene
Source Source Link

Details

PrimaryID629
RefseqGeneNG_008191
SymbolCFB
Namecomplement factor B
Chromosome6
Location6p21.33
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1993-11-10
ModificationDate2021-06-20

Ontological Relatives

UniProt IDsCFAB_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001848 complement binding
GO:0004252 serine-type endopeptidase activity
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005886 plasma membrane
GO:0006956 complement activation
GO:0006957 complement activation, alternative pathway
GO:0030449 regulation of complement activation
GO:0070062 extracellular exosome
GO:0072562 blood microparticle

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615561 OMIMComplement factor B deficiency (CFBD)An immunologic disorder characterized by increased susceptibility to bacterial infections, particularly Neisseria infections, due to a defect in the alternative complement pathway. The disease is caused by variants affecting the gene represented in this entry.
615489 OMIMMacular degeneration, age-related, 14 (ARMD14)A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. Disease susceptibility may be associated with variants affecting the gene represented in this entry. Haplotype analyses have identified a statistically significant common risk haplotype and two protective haplotypes. CFB variant His-9 and C2 variant Asp-318, as well as CFB variant Gln-32 and a variant in intron 10 of C2, confer a significantly reduced risk of AMD.
612924 OMIMHemolytic uremic syndrome atypical 4 (AHUS4)An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. Disease susceptibility is associated with variants affecting the gene represented in this entry. Susceptibility to the development of atypical hemolytic uremic syndrome can be conferred by mutations in various components of or regulatory factors in the complement cascade system. Other genes may play a role in modifying the phenotype.

Interactions

18 interactions